Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of presentation and outcomes in stage IV Hodgkin lymphoma: A report from the Children's Oncology Group (COG) AHOD1331 trial.

British journal of haematology·2026
Same author

E Lesion or Stage IV disease? An Ongoing Unsettled Issue in Pediatric Hodgkin Lymphoma.

Blood advances·2026
Same author

Immunoglobulin Supplementation Practices and Effects During Pediatric B-Cell Acute Lymphoblastic Leukemia Therapy.

Journal of pediatric hematology/oncology·2026
Same author

Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma.

Leukemia & lymphoma·2026
Same author

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026

Related Experiment Video

Updated: Jan 9, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.5K

An efficient single-arm Bayesian adaptive trial algorithm to evaluate de-intensified oncologic treatment.

Yuan Zhong1, Zeynep Baskurt1, Mahmood Aminilari2

  • 1Biostatistics Department, University Health Network, Toronto, ON, Canada.

Trials
|December 10, 2025
PubMed
Summary

This study presents a Bayesian adaptive method for clinical trial design, improving efficiency for rare cancers and de-intensified treatments. The BayesAT R package aids in analyzing survival data and making faster treatment efficacy conclusions.

Keywords:
Bayesian adaptive trialBayesian statisticsMulti-stage interim analysisSingle-arm trial

More Related Videos

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
10:13

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Published on: June 21, 2022

2.6K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.6K

Related Experiment Videos

Last Updated: Jan 9, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.5K
Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
10:13

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Published on: June 21, 2022

2.6K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.6K

Area of Science:

  • Oncology
  • Biostatistics
  • Clinical Trial Design

Background:

  • Evaluating de-intensified oncologic treatments can reduce patient toxicity and improve quality of life.
  • Challenges exist in rare cancers due to long trial durations needed for sufficient event data.
  • Traditional randomized trials may be impractical for uncommon cancers requiring de-intensified strategies.

Purpose of the Study:

  • Introduce a Bayesian adaptive method for single-arm trial design.
  • Enable efficient analysis of survival data in challenging clinical trial settings.
  • Facilitate robust estimations and predictions for trial design and sample size determination.

Main Methods:

  • Utilizes a Bayesian adaptive approach incorporating prior knowledge and historical control arms.
  • Employs an R package, "BayesAT," for flexible modeling and multi-stage interim analyses.
  • Designed for efficient survival data analysis, particularly for de-intensified oncologic treatments.

Main Results:

  • The method's validity is confirmed through extensive simulation studies and sensitivity analyses.
  • Successfully applied to a pediatric Hodgkin lymphoma trial.
  • Demonstrates effective use of prior information and interim analyses to accelerate conclusions.

Conclusions:

  • The Bayesian adaptive method offers an efficient approach for clinical trials with survival data constraints.
  • The "BayesAT" package provides a practical tool for implementing this method.
  • This approach expedites conclusions on treatment efficacy, especially for de-intensified strategies in rare cancers.